13.2 Toxicology and Health Impacts of Nanomaterials
3 min read•july 25, 2024
Nanomaterials pose unique health risks due to their size and properties. Exposure can occur through , skin contact, or ingestion, potentially affecting various organs. Understanding these risks is crucial for developing safe practices in nanotechnology.
Toxicity mechanisms of nanomaterials include oxidative stress, inflammation, and cellular disruption. Assessing their safety is challenging due to material variability and limitations of traditional testing methods. Proper handling and safety measures are essential to minimize risks in research and manufacturing settings.
Health Risks and Toxicity of Nanomaterials
Health risks of nanomaterial exposure
Top images from around the web for Health risks of nanomaterial exposure
Frontiers | Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19 View original
Is this image relevant?
Environmental and Health Safety Considerations of Nanotechnology: Nano Safety View original
Is this image relevant?
Retained particle surface area dose drives inflammation in rat lungs following acute, subacute ... View original
Is this image relevant?
Frontiers | Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19 View original
Is this image relevant?
Environmental and Health Safety Considerations of Nanotechnology: Nano Safety View original
Is this image relevant?
1 of 3
Top images from around the web for Health risks of nanomaterial exposure
Frontiers | Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19 View original
Is this image relevant?
Environmental and Health Safety Considerations of Nanotechnology: Nano Safety View original
Is this image relevant?
Retained particle surface area dose drives inflammation in rat lungs following acute, subacute ... View original
Is this image relevant?
Frontiers | Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19 View original
Is this image relevant?
Environmental and Health Safety Considerations of Nanotechnology: Nano Safety View original
Is this image relevant?
1 of 3
- Exposure routes include inhalation of airborne nanoparticles in occupational settings, dermal contact through cosmetics or sunscreens, and ingestion via food packaging or medical treatments
- Potential target organs affected by nanoparticle accumulation encompass lungs (respiratory distress), skin (irritation), liver (hepatotoxicity), kidneys (nephrotoxicity), and brain ()
- Nanoparticle-specific risks arise from enhanced penetration through biological barriers (blood-brain barrier), increased surface reactivity leading to cellular damage, and potential for bioaccumulation in organs
- Occupational hazards present in manufacturing processes (inhalation of metal fumes), research laboratories (handling of engineered nanomaterials), and during transportation (accidental spills)
Mechanisms of nanomaterial toxicity
- Oxidative stress triggers generation of reactive oxygen species (ROS) causing lipid peroxidation in cell membranes and DNA damage leading to mutations
- Inflammation induced by nanoparticles prompts cytokine release and immune system activation resulting in tissue damage
- Cellular uptake mechanisms involve endocytosis for smaller particles and phagocytosis for larger agglomerates affecting intracellular distribution
- Protein corona formation on nanoparticle surfaces alters their biological identity influencing cellular recognition and potential toxicity
- Genotoxicity occurs through direct DNA damage from nanoparticle interactions or indirect effects via oxidative stress pathways
- Disruption of cellular processes includes mitochondrial dysfunction impacting energy production and cell membrane damage affecting cellular homeostasis
Assessment and Safety Practices
Challenges in nanomaterial toxicity assessment
- Variability in nanomaterial properties such as size, shape, surface chemistry, and agglomeration state complicates toxicity predictions
- Lack of standardized characterization methods creates difficulties in measuring nanoparticle concentration and maintaining stable dispersions for consistent testing
- Limited applicability of traditional toxicity assays due to potential interference with assay readouts necessitates development of nano-specific endpoints
- Dosimetry issues arise when expressing dose in terms of mass, surface area, or particle number and accounting for particle settling and diffusion in in vitro systems
- Extrapolation from in vitro to in vivo effects faces limitations of cell culture models and species differences in toxicity responses
- Long-term effects and chronic require time-consuming and resource-intensive studies with difficulty in mimicking real-world exposure scenarios
Safe practices for nanomaterial handling
- Engineering controls include fume hoods for containment, glove boxes for isolation, and local exhaust ventilation to remove airborne particles
- Personal protective equipment (PPE) encompasses respirators (N95 or higher), chemical-resistant gloves, and protective clothing to minimize exposure
- Workplace practices involve implementing standard operating procedures (SOPs), conducting regular training programs, and performing exposure monitoring
- Spill containment and cleanup utilize specialized vacuum cleaners with HEPA filters and wet cleaning methods to prevent particle resuspension
- Waste management requires proper labeling and segregation of nanomaterial waste, treatment before disposal, and compliance with hazardous waste regulations
- Environmental considerations focus on preventing release into air, water, or soil and assessing potential for bioaccumulation in ecosystems (aquatic organisms)
- Risk assessment and management involve identifying potential hazards, implementing control measures, and regularly reviewing and updating safety protocols
Key Terms to Review (13)
Animal Models: Animal models refer to non-human animals that are used in research to study biological and pathological processes, as well as to test the safety and efficacy of new treatments. They play a critical role in toxicology, particularly in understanding the health impacts of nanomaterials by simulating human responses to various substances, allowing researchers to evaluate potential risks before human trials.
Bioavailability: Bioavailability refers to the proportion of a drug or therapeutic agent that enters the systemic circulation when it is introduced into the body and is available for action at the intended site. This concept is crucial in understanding how effectively a treatment can work, as it determines how much of the administered substance actually reaches its target, especially in the context of nanomaterials designed for drug delivery. In addition, bioavailability plays a significant role in assessing the potential health impacts of these materials, as variations in absorption can influence both therapeutic efficacy and toxicity.
Carbon nanotubes: Carbon nanotubes are cylindrical structures made of carbon atoms arranged in a hexagonal lattice, exhibiting remarkable strength, electrical conductivity, and thermal properties. These unique materials can exist as single-walled or multi-walled structures and play a critical role in nanotechnology applications due to their exceptional mechanical and electronic characteristics.
Dermal exposure: Dermal exposure refers to the contact of substances, such as chemicals or nanoparticles, with the skin, which can lead to potential absorption into the body. This type of exposure is particularly relevant in discussions of nanomaterials, as their small size and unique properties may enhance skin penetration and increase health risks.
Exposure Assessment: Exposure assessment is the process of estimating or measuring the magnitude, frequency, and duration of exposure to a particular substance, in this case, nanomaterials. It plays a critical role in understanding the potential health risks and toxicological effects associated with nanomaterials, as it helps to identify vulnerable populations and specific exposure pathways. By determining how and when individuals may come into contact with these materials, exposure assessment informs risk management strategies and regulatory guidelines.
Inhalation: Inhalation is the process of taking air into the lungs through the nose or mouth, which can also involve the uptake of airborne particles, including nanomaterials. This process is crucial in understanding how these tiny materials can enter the human body and potentially cause various health effects, as the lungs have a large surface area and are designed for efficient gas exchange.
Neurotoxicity: Neurotoxicity refers to the adverse effects that substances, such as certain chemicals or nanomaterials, can have on the nervous system, leading to potential damage to neurons and disruption of normal brain function. This phenomenon is particularly significant in understanding how exposure to various materials can result in cognitive impairments, behavioral changes, and other neurological disorders. The relevance of neurotoxicity in the context of health impacts emphasizes the need to assess risks associated with nanomaterials, which may possess unique properties that alter their interaction with biological systems.
NRC Report: The NRC Report refers to the comprehensive assessments and recommendations published by the National Research Council regarding the environmental, health, and safety implications of nanotechnology. It serves as a vital resource for understanding the potential risks and benefits associated with nanomaterials, particularly in relation to their toxicology and health impacts.
Pulmonary Toxicity: Pulmonary toxicity refers to the harmful effects of substances, including nanomaterials, on the lungs and respiratory system. This condition can arise from exposure to inhaled particles that lead to inflammation, oxidative stress, and potential long-term damage to lung tissues. Understanding pulmonary toxicity is critical for assessing the health risks associated with nanomaterials in various applications, especially in medicine and industry.
Quantum Dots: Quantum dots are tiny semiconductor particles, typically ranging from 2 to 10 nanometers in size, that exhibit quantum mechanical properties. Their unique size allows them to confine electrons and holes in three dimensions, leading to quantized energy levels that give quantum dots their distinct optical and electronic properties, making them significant in various advanced technologies.
Risk characterization: Risk characterization is the process of summarizing and interpreting the results of risk assessment to provide a clear understanding of the potential health and environmental risks associated with exposure to certain materials or substances. This involves integrating information about hazard identification, exposure assessment, and dose-response relationships, leading to informed decision-making regarding safety measures and regulatory actions.
TSCA: The Toxic Substances Control Act (TSCA) is a U.S. law that regulates the introduction of new or already existing chemicals. It empowers the Environmental Protection Agency (EPA) to evaluate the safety of chemicals, ensuring that they do not pose an unreasonable risk to health or the environment. TSCA is particularly important in addressing potential health impacts from substances, including nanomaterials, and plays a key role in risk assessment and management processes for these advanced materials.
WHO Guidelines: The WHO Guidelines refer to the recommendations and frameworks established by the World Health Organization to ensure the safety and effective use of nanomaterials, particularly in healthcare and environmental applications. These guidelines aim to provide a comprehensive approach to assessing the risks associated with nanomaterials and to promote public health by ensuring that any potential health impacts are thoroughly evaluated and managed.